Previous 10 | Next 10 |
Co-Diagnostics, Inc. (CODX) Q2 2022 Earnings Conference Call August 11, 2022 04:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chairman, President and Chief Executive Officer Brian Brown - Chief Financial Officer Conf...
Shares of Co-Diagnostics ( NASDAQ: CODX ) have slumped 36.5% to $4.10 in Thursday postmarket trading, after the molecular diagnostics company posted Q2 results that missed estimates, with its revenue hit by volume declines. Its Q2 revenue of $5.02M fell 81.7% Y/Y a...
Co-Diagnostics press release ( NASDAQ: CODX ): Q2 GAAP EPS of -$0.08 misses by $0.18 . Revenue of $5.02M (-81.7% Y/Y) misses by $13.98M . Shares -24.3% . For further details see: Co-Diagnostics GAAP EPS of -$0.08 misses by $0.18, revenue of $5.02M...
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results PR Newswire Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform SALT LAKE CITY , Aug. 11, 2022 /PRNewswire/ ...
According to the latest data compiled by the Centers for Disease Control and Prevention (CDC), the recent monkeypox outbreak has led to 10,392 cases as of Wednesday. The country has added 900 cases on Wednesday alone per the Our World in Data project, a public online data hub base...
Co-Diagnostics (NASDAQ: CODX) , a maker of molecular diagnostics tests, fell 10% on Tuesday. The stock closed at $7.01 a share on Monday, then opened at $6.95 on Wednesday before dropping to a low of $6.30 shortly before 2 p.m. ET. Co-Diagnostics has a 52-week low of $3.66 and a hig...
The Biden administration declared the current monkeypox outbreak a public health emergency on Thursday in a bid to marshal resources and raise awareness to contain the fast-spreading virus. Previously, The Washington Post reported the government plans, citing two officials. “...
The Biden administration is expected to declare the current monkeypox outbreak a public health emergency as soon as Thursday, The Washington Post reported Thursday. The Health and Human Services Secretary Xavier Becerra is expected to make the announcement at an afternoon briefing...
President Joe Biden appointed two top federal officials to lead the U.S. response against monkeypox, the White House announced Tuesday, as the ongoing outbreak has prompted more states to declare emergencies to contain the virus. Robert Fenton, who currently serves as Regional Admin...
Companies focused on developing solutions against monkeypox jumped in the pre-market Monday after New York became the second major U.S. city to call the current outbreak a public health emergency. Announcing the decision on Saturday, New York Mayor Eric Adams and Dr. Ashwin Vasan, c...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...